LEILANI WEAVER: Open Payments
NPI 1316515943 · COLFAX, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $80 |
| Lilly USA, LLC | 2 | $51 |
| Novo Nordisk Inc | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| Exact Sciences Corporation | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: QULIPTA, MOUNJARO, JARDIANCE, The Cologuard Plus Collection Kit, NURTEC ODT, Rybelsus, Ozempic, UBRELVY.
Industry payments across WA — which companies pay providers there.
